VC  Sanderling Ventures

     Office Locations:

1010 Sherbrooke St. W Suite 408
Montreal, Quebec QC H3A 2R7
Phone: 514-564-6474

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.


  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 1979, Sanderling has supported over 90 biomedical companies from very early stages through commercial development. Sanderling focuses on new biomedical market opportunities including emerging technology in the following areas: Biotechnology, Therapeutics and pharmaceuticals, Drug delivery, Medical devices and instrumentation, Imaging and diagnostics, Medical Informatics, and Health care services.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Fred Middleton Managing Director
    Paulette Taylor General Counsel & Principal
    Peter McWilliams Ph.D. Managing Director
    Robert Abrams Operating Partner
    Robert McNeil Ph.D. Managing Director


    Recent Funding Events (trailing 12 months):










      Series D


    Portfolio companies include:

      Altor Bioscience
        web link

        web link

        web link

      Axikin Pharmaceuticals
        web link

        web link

        web link

        web link

        web link

        web link

        web link

        web link

        web link

        web link

      Pulsar Vascular
        web link

      Sotera Wireless
        web link

        web link

        web link

        web link

      Torax Medical
        web link

        web link

        web link


    Recent News: